CSIMarket


Compass Therapeutics Inc   (NASDAQ: CMPX)
Other Ticker:  
 

Compass Therapeutics Inc

CMPX's Fundamental analysis








Compass Therapeutics Inc 's sales fell in IV. Quarter 2024 from the same quarter a year ago.

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -2.61 %

Compass Therapeutics Inc net loss increased from $-13 millions, to $-15 millions in IV. Quarter 2024,

More on CMPX's Growth


Compass Therapeutics Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 16.45 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 372.73.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.55.


More on CMPX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 0.91

Compass Therapeutics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 16.45 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 372.73.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.55.

Compass Therapeutics Inc Price to Book Ratio is at 2.53 lower than Industry Avg. of 1411.8. and higher than S&P 500 Avg. of 0.01

More on CMPX's Valuation

  Market Capitalization (Millions $) 317
  Shares Outstanding (Millions) 137
  Employees 99
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -49
  Cash Flow (TTM) (Millions $) 19
  Capital Exp. (TTM) (Millions $) -
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 0.91

  Market Capitalization (Millions $) 317
  Shares Outstanding (Millions) 137
  Employees 99
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -49
  Cash Flow (TTM) (Millions $) 19
  Capital Exp. (TTM) (Millions $) -





  Ratio
   Capital Ratio (MRQ) 14.96
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.12
  Asset Turnover Ratio (TTM) -
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com